LUNG Q1 2021 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$9M+7.3% YoY

Gross Profit

$7M71.5% margin

Operating Income

-$12M-135.2% margin

Net Income

-$13M-135.4% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-6.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$255M

Total Liabilities

$39M

Stockholders' Equity

$217M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$9M	+7.3%
Gross Profit	$7M	$6M	+17.0%
Operating Income	-$12M	-$6M	-104.7%
Net Income	-$13M	-$7M	-74.7%

Geographic Segments

UNITED STATES

$4M46%

EMEA

$4M44%

Asia Pacific

$911,00010%